CCM
GILD icon

Channing Capital Management’s Gilead Sciences GILD Stock Holding History

Channing Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.07M Sell
71,811
-9,588
-12% -$1.26M 0.21% 91
2026
Q1 		$11.3M Sell
81,399
-12,290
-13% -$1.72M 0.29% 58
2025
Q4 		$11.5M Sell
93,689
-7,867
-8% -$956K 0.3% 59
2025
Q3 		$11.3M Sell
101,556
-328
-0.3% -$37.3K 0.3% 61
2025
Q2 		$11.3M Buy
101,884
+43,875
+76% +$4.67M 0.31% 52
2025
Q1 		$6.5M Sell
58,009
-40,649
-41% -$4.19M 0.2% 91
2024
Q4 		$9.11M Sell
98,658
-6,347
-6% -$571K 0.24% 72
2024
Q3 		$8.8M Buy
+105,005
New +$8.01M 0.23% 80
2020
Q1 		– Sell
-124,753
Closed -$8.11M – 115
2019
Q4 		$8.11M Sell
124,753
-577
-0.5% -$37.6K 0.38% 78
2019
Q3 		$7.94M Buy
125,330
+12,416
+11% +$812K 0.37% 74
2019
Q2 		$7.63M Buy
112,914
+21,225
+23% +$1.4M 0.35% 70
2019
Q1 		$5.96M Buy
+91,689
New +$6.09M 0.28% 85
2018
Q2 		– Sell
-110,567
Closed -$8.34M – 107
2018
Q1 		$8.34M Buy
110,567
+149
+0.1% +$11.8K 0.29% 73
2017
Q4 		$7.91M Buy
110,418
+3
+0% +$228 0.27% 80
2017
Q3 		$8.95M Buy
110,415
+3,675
+3% +$281K 0.34% 69
2017
Q2 		$7.55M Buy
106,740
+5,216
+5% +$347K 0.3% 76
2017
Q1 		$6.9M Buy
101,524
+14,956
+17% +$1.05M 0.25% 82
2016
Q4 		$6.2M Sell
86,568
-20,290
-19% -$1.51M 0.22% 88
2016
Q3 		$8.46M Buy
106,858
+7,015
+7% +$570K 0.34% 74
2016
Q2 		$8.33M Buy
+99,843
New +$8.86M 0.35% 72

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Channing Capital Management's GILD Position: Q2 2026 in Review

Channing Capital Management reduced its Gilead Sciences (GILD) stake by 12% in Q2 2026, selling an estimated $1.26M and leaving 71,811 shares worth $9.07M. The position accounts for 0.21% of the portfolio, ranked #91.

Channing Capital Management first reported a position in GILD in Q2 2016 and has held it in 20 quarters since. The position peaked at $11.5M in Q4 2025. 2,274 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Channing Capital Management held 71,811 shares of Gilead Sciences worth $9.07M as of Q2 2026.
  • Channing Capital Management sold 9,588 Gilead Sciences shares in Q2 2026, an estimated $1.26M.
  • Gilead Sciences made up 0.21% of Channing Capital Management's portfolio in Q2 2026, its #91 holding.
  • Channing Capital Management first reported a position in Gilead Sciences in Q2 2016 and has held it in 20 quarters since.
  • Channing Capital Management's Gilead Sciences position peaked at $11.5M in Q4 2025.
  • 2,274 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Channing Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.